Please log in to view this page
Username
Password
PK, safety and acceptability data and practical guidance on the optimal dosing of new more child-friendly formulations of...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
A single dose of nevirapine (SD NVP) given to an HIV infected pregnant woman followed by a single dose to her infant has been...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
IMPAACT 2010 is a Phase III, three-arm, randomized, open-label study of HIV-1-infected pregnant women initiating either a...
